Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-014623
Filing Date
2020-06-10
Accepted
2020-06-10 17:42:19
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1539
  Complete submission text file 0001213900-20-014623.txt   2988
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Issuer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1920 MCKINNEY AVENUE, 7TH FLOOR DALLAS TX 75201
Business Address
Margrave David R. (Reporting) CIK: 0001813162 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39318 | Film No.: 20955605